Ratings
0
Nobody has rated this yet. Be the first!
Works
5
Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab
Identifying and targeting ROS1 gene fusions in non-small cell lung cancer
Crizotinib in ROS1-rearranged non-small-cell lung cancer.
Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer.
Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients
